Stephen Kinnock

I thank the shadow Minister for his questions. He asked about first awareness of what was happening with Jhoots. He will be aware that it entered the market through the purchase of a number of Lloyds pharmacies that were no longer a going concern in 2023, so the question about due diligence on Jhoots as an operator is probably something he should be asking one of my predecessors from his party, which was in power at the time. Since those purchases, Jhoots has expanded rapidly, and that has been where we have seen the question marks around its ability to operate and the serious downgrading of services. I have not met the management of Jhoots. We are looking at a whole range of legal and regulatory enforcement procedures, and the decision we have taken is that it is better not to interfere in any way in those processes, but I am certainly monitoring that very closely. If we receive legal advice that suggests that such a meeting would be a good idea, I will of course be open to it. However, the current legal position based on the advice we have received is that it would not be appropriate at this time. On local pharmacy access, integrated care boards have a statutory responsibility to ensure adequate pharmacy provision. Some ICBs, for example, have allowed dispensing GP practices to provide dispensing services to affected patients, while others have worked with local GP practices to advise patients to nominate alternative nearby pharmacies for their prescriptions. We have looked at the impact geographically, and our view is that in most cases there is alternative pharmacy provision to Jhoots within striking distance. However, there are four or five areas of the country where that is not the case, including in the constituency of the hon. Member for West Dorset (Edward Morello), who secured this urgent question. I am very conscious of that. In those cases, extra provision needs to be made through ICBs and GPs—that may be through distance selling or by other means—to ensure that patients have pharmacy access. The shadow Minister asks about continuity of care and national contingency. The situation is challenging because, as I mentioned in my remarks and as officials have said, we have not seen this rapid decline in service before. We are working at pace to strengthen the regulatory framework and we are looking at contingency plans. I do not see any reason why the overall funding settlement for pharmacy should be undermined. We will continue to protect community pharmacy as a crucial part of our NHS.